Severity: Notice
Message: MemcachePool::get(): Server 127.0.0.1 (tcp 11211, udp 0) failed with: Connection refused (111)
Filename: drivers/Cache_memcached.php
Line Number: 142
Backtrace:
File: /home/theinjobs/public_html/application/controllers/Indeed.php
Line: 536
Function: get
File: /home/theinjobs/public_html/application/controllers/Indeed.php
Line: 863
Function: indeed_job_details
File: /home/theinjobs/public_html/index.php
Line: 316
Function: require_once
Employment Type : Full-Time
Description Primary Responsibilities: Management team and Biostatistics. Requirements Working Conditions and Physical Requirements The preceding job description indicates the general nature and level of work performed by employees within this classification. Additional and incidental duties related to the primary duties may be required from time to time. For consideration send cover letter and resume to: ww.fatetherapeutics.com and reference job code 406SR. About Fate Therapeutics, Inc. Job Type: Full-time Benefits: Schedule: Supplemental Pay: Work Location: This Company Describes Its Culture as: Company's website:
Fate’s Clinical Data Management group is currently seeking an experienced Clinical Data Manager to be responsible for data management activities for clinical trials from startup to closeout, as well as process improvement activities and department initiatives. This role will work with internal colleagues and external vendors to ensure delivery to time, quality, and cost expectations. Perform day-to-day data management activities according to ICH guidelines, regulatory requirements, and the company's standard operating procedures. This position reports to the Director, Clinical Data Management and is located at our corporate headquarters in San Diego, California.
Fate Therapeutics is a clinical-stage biopharmaceutical company dedicated to the development of first- in-class cellular immunotherapies for cancer and immune disorders. The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform. The Company’s immuno- oncology product candidates include natural killer (NK) cell and T-cell cancer immunotherapies, which are designed to synergize with well-established cancer therapies, including immune checkpoint inhibitors and monoclonal antibodies, and to target tumor-associated antigens with chimeric antigen receptors (CARs). The Company’s immuno-regulatory product candidates include ProTmune™, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA. For more information, please visit www.fatetherapeutics.com.